Clinical Strategies in the Management of Diabetic Retinopathy A Step
The advent of intravitreal treatment with anti-vascular endothelium growth factor (anti-VEGF) antibodies and steroids has revolutionized the management of diabetic retinopathy. This timely 2nd edition delves into therapies involving anti-VEGF, and address
- PDF / 27,420,803 Bytes
- 300 Pages / 439.43 x 683.15 pts Page_size
- 43 Downloads / 179 Views
123
Clinical Strategies in the Management of Diabetic Retinopathy
Francesco Bandello • Marco Attilio Zarbin Rosangela Lattanzio • Ilaria Zucchiatti Editors
Clinical Strategies in the Management of Diabetic Retinopathy A Step-by-Step Guide for Ophthalmologists Second Edition
Editors Francesco Bandello Department of Ophthalmology Vita-Salute University San Raffaele Scientific Institute Milan Italy
Marco Attilio Zarbin Institute of Ophthalmology and Visual Science Rutgers-New Jersey Medical School Rutgers University Newark, NJ USA
Rosangela Lattanzio Department of Ophthalmology Vita-Salute University San Raffaele Scientific Institute Milan Italy
Ilaria Zucchiatti Department of Ophthalmology Vita-Salute University San Raffaele Scientific Institute Milan Italy
ISBN 978-3-319-96156-9 ISBN 978-3-319-96157-6 (eBook) https://doi.org/10.1007/978-3-319-96157-6 Library of Congress Control Number: 2018955738 © Springer Nature Switzerland AG 2019 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors, and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. This Springer imprint is published by the registered company Springer Nature Switzerland AG The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland
This book is dedicated to Professor Rosario Brancato, who was a master and a pioneer in the field of diabetic retinopathy diagnosis and treatment.
Foreword
A new era in the management of diabetic retinopathy has started, offering for the first time recovery of visual acuity compared to previous treatments, such as laser photocoagulation, which aimed at disease stabilization. New evidence emerging from randomized clinical trials showed the effectiveness of intravitreal treatment with anti-vascular endothelium growth factor antibodies and steroids in the management of diabetic retinopathy. Moreover, combined treatment strategies and new surgical techniques to date play a significant role, especially
